TRCT
PILL icon

Tower Research Capital (TRC)’s Direxion Daily Pharmaceutical & Medical Bull 3X ETF PILL Stock Holding History

Tower Research Capital (TRC)’s Portfolio PILL Stock Details PILL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$105K Sell
5,823
-78
-1% -$997 ﹤0.01% 2151
2026
Q1 		$60.3K Buy
5,901
+5,834
+8,707% +$68.4K ﹤0.01% 2586
2025
Q4 		$824 Sell
67
-54,615
-100% -$547K ﹤0.01% 4811
2025
Q3 		$441K Buy
54,682
+10,700
+24% +$72.5K 0.01% 959
2025
Q2 		$227K Sell
43,982
-64,739
-60% -$336K 0.01% 1659
2025
Q1 		$785K Buy
+108,721
New +$814K 0.02% 605
2024
Q4 		– Sell
-29,091
Closed -$239K – 5928
2024
Q3 		$239K Sell
29,091
-2,438
-8% -$18.3K 0.01% 1453
2024
Q2 		$196K Buy
+31,529
New +$210K ﹤0.01% 2086
2024
Q1 		– Sell
-33,769
Closed -$262K – 6072
2023
Q4 		$262K Buy
+33,769
New +$203K ﹤0.01% 1879
2023
Q2 		– Sell
-5,210
Closed -$45K – 6287
2023
Q1 		$45K Sell
5,210
-8,672
-62% -$82K ﹤0.01% 2592
2022
Q4 		$125K Buy
13,882
+6,195
+81% +$59.6K 0.01% 1658
2022
Q3 		$68K Sell
7,687
-30,410
-80% -$337K ﹤0.01% 2886
2022
Q2 		$412K Sell
38,097
-8,539
-18% -$95.6K 0.01% 1259
2022
Q1 		$675K Buy
46,636
+17,881
+62% +$241K 0.01% 981
2021
Q4 		$457K Buy
+28,755
New +$502K 0.01% 1173
2021
Q3 		– Sell
-10,562
Closed -$250K – 6067
2021
Q2 		$250K Buy
+10,562
New +$230K 0.01% 1756
2020
Q3 		– Sell
-31,856
Closed -$491K – 5035
2020
Q2 		$491K Buy
+31,856
New +$449K 0.02% 1056
2020
Q1 		– Sell
-17,084
Closed -$432K – 3690
2019
Q4 		$432K Buy
17,084
+1,643
+11% +$28K 0.04% 306
2019
Q3 		$192K Buy
15,441
+13,421
+664% +$196K 0.01% 1027
2019
Q2 		$36K Buy
+2,020
New +$39.4K ﹤0.01% 1800

Other funds holding PILL

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
GS
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FC
Financial Consulate Hunt Valley, Maryland $899M AUM 20.23% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Tower Research Capital (TRC)'s PILL Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) stake by 1.3% in Q2 2026, selling an estimated $997 and leaving 5,823 shares worth $105K. The position accounts for ﹤0.01% of the portfolio, ranked #2151.

Tower Research Capital (TRC) first reported a position in PILL in Q2 2019 and has held it in 20 quarters since. The position peaked at $785K in Q1 2025. 7 funds tracked by Wall St. Rank hold PILL as of Q2 2026.

  • Tower Research Capital (TRC) held 5,823 shares of Direxion Daily Pharmaceutical & Medical Bull 3X ETF worth $105K as of Q2 2026.
  • Tower Research Capital (TRC) sold 78 Direxion Daily Pharmaceutical & Medical Bull 3X ETF shares in Q2 2026, an estimated $997.
  • Direxion Daily Pharmaceutical & Medical Bull 3X ETF made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #2151 holding.
  • Tower Research Capital (TRC) first reported a position in Direxion Daily Pharmaceutical & Medical Bull 3X ETF in Q2 2019 and has held it in 20 quarters since.
  • Tower Research Capital (TRC)'s Direxion Daily Pharmaceutical & Medical Bull 3X ETF position peaked at $785K in Q1 2025.
  • 7 funds tracked by Wall St. Rank held Direxion Daily Pharmaceutical & Medical Bull 3X ETF as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.